Heron Therapeutics (HRTX) Research & Development: 2010-2025
Historic Research & Development for Heron Therapeutics (HRTX) over the last 12 years, with Sep 2025 value amounting to $3.5 million.
- Heron Therapeutics' Research & Development fell 22.28% to $3.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $11.9 million, marking a year-over-year decrease of 44.33%. This contributed to the annual value of $16.7 million for FY2024, which is 57.37% down from last year.
- Heron Therapeutics' Research & Development amounted to $3.5 million in Q3 2025, which was up 18.27% from $2.9 million recorded in Q2 2025.
- In the past 5 years, Heron Therapeutics' Research & Development ranged from a high of $42.1 million in Q1 2022 and a low of -$13.7 million during Q4 2022.
- Over the past 3 years, Heron Therapeutics' median Research & Development value was $4.5 million (recorded in 2024), while the average stood at $5.9 million.
- In the last 5 years, Heron Therapeutics' Research & Development crashed by 147.60% in 2022 and then soared by 156.76% in 2023.
- Quarterly analysis of 5 years shows Heron Therapeutics' Research & Development stood at $28.9 million in 2021, then slumped by 147.60% to -$13.7 million in 2022, then skyrocketed by 156.76% to $7.8 million in 2023, then crashed by 59.27% to $3.2 million in 2024, then declined by 22.28% to $3.5 million in 2025.
- Its last three reported values are $3.5 million in Q3 2025, $2.9 million for Q2 2025, and $2.3 million during Q1 2025.